Kamada (KMDA) EV to EBITDA (2016 - 2026)
Kamada's EV to EBITDA came in at 8.19 for the quarter ended Jun 30, 2026, down 13.8% from 9.51 a year earlier and down 18.6% from the prior quarter.
Powered by 
Analysis
Kamada (KMDA) EV to EBITDA (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kamada reported EV to EBITDA of 3.07, down 19.8% year-over-year; for the year ended Dec 31, 2025, it was 8.06, up 0.4% from the prior year.
- Going back by year, EV to EBITDA was 8.03 in the year ended Dec 31, 2024 (-38.2%), 12.99 in the year ended Dec 31, 2023 (+49.0%), 8.72 in the year ended Dec 31, 2022 (-84.5%) and 56.20 in the year ended Dec 31, 2021 (+650.8%).
- The five-year range for quarterly EV to EBITDA is 7.61 (the quarter ended Sep 30, 2025) to 63.71 (the quarter ended Jun 30, 2022).
- Year-over-year, EV to EBITDA increased in three of the last eight quarters, with an average decline of 3.5%.
- The fastest year-over-year change in EV to EBITDA over five years came in the quarter ended Jun 30, 2022 (growth of 664.9%), and the weakest in the quarter ended Jun 30, 2023 (a decline of 84.6%).
- Business Quant data shows KMDA's EV to EBITDA at 10.06 (quarter ended Mar 31, 2026), 8.06 (quarter ended Dec 31, 2025) and 7.61 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Kamada | 497.25 Mn | 206.31 Mn | 22.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.19 |
| Mar 31, 2026 | 10.06 |
| Dec 31, 2025 | 8.06 |
| Sep 30, 2025 | 7.61 |
| Jun 30, 2025 | 9.51 |
| Mar 31, 2025 | 8.00 |
| Dec 31, 2024 | 8.03 |
| Sep 30, 2024 | 7.72 |
| Jun 30, 2024 | 7.70 |
| Mar 31, 2024 | 10.29 |
| Dec 31, 2023 | 12.99 |
| Sep 30, 2023 | 7.84 |
| Jun 30, 2023 | 9.82 |
| Mar 31, 2023 | 10.75 |
| Dec 31, 2022 | 8.72 |
| Sep 30, 2022 | 20.45 |
| Jun 30, 2022 | 63.71 |
| Mar 31, 2022 | 48.20 |
| Dec 31, 2021 | 56.20 |
| Sep 30, 2021 | 13.55 |
API Access
Kamada EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=KMDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();